经皮椎体成形术与椎体后凸成形术治疗胸腰椎压缩性骨折的临床疗效比较

目的比较经皮椎体成形术与椎体后凸成形术治疗胸腰椎压缩性骨折的临床疗效。方法对98例胸腰椎压缩性骨折，根据手术方法不同分为椎体成形组和椎体后凸成形组。比较两组术前术后椎体前缘、中线、后缘高度变化，疼痛视觉模糊评分（VAS），手术时间，出血量等方面的差异。结果两组对椎体高度的恢复比较差异有统计学意义（P〈0．01），VAS、手术时间和出血量比较差异无统计学意义（P〉0．05）。结论经皮椎体成形术与椎体后凸成形术具有创伤小、手术时间短、出血量少等微创优点，而椎体后凸成形术具有较好的复位作用。     

微创经皮钢板骨桥接术联合锁定加压钛板治疗胫骨远端骨折

目的探讨微创经皮钢板骨桥接术（minimallyi nvasive percutaneous plate osteosynthesis，MIPPO）联合锁定加压钛板（locking compression plate，LCP）治疗胫骨远端骨折的近期疗效。方法2004年6月～2006年3月采用MIPPO联合LCP治疗胫骨远端骨折16例，AO分型：43A1型7例，43A3型5例，43B1型2例，43C3型2例。采用3种方法复位胫骨骨折后插入LCP，用锁定螺钉固定。结果16例随访5～20个月，平均11，5月。16例切口一期愈合，骨折无延迟愈合、畸形愈合、断钉、断板等并发症。术后X线检查4～12周（平均7．6周）骨痂形成并开始部分负重，8～20周骨性愈合（平均16周），此时开始完全负重。3例出现胫骨远端内植物局部不适。根据美国足踝骨科学会评分系统对踝关节功能评分，优14例（87．5％），良2例（12，5％）。结论MIPPO具有创伤小、固定牢靠、可早期功能锻炼等优点，近期疗效满意，是治疗胫骨远端骨折的有效方法。     

雌激素受体亚型与多囊卵巢综合征

雌激素受体有两种亚型,即雌激素受体α和β,这两种亚型具有几乎相同的DNA结合区与较类似的配体结合区,但在不同的组织、器官中的分布和表达不一,与配体结合后的生物学效应也不尽相同,从而产生不同的生理和病理作用。研究发现,雌激素受体α和β亚型在生殖系统中的表达和比例异常可能与多囊卵巢综合征生殖功能障碍及生殖系统疾病相关。就雌激素受体α及β亚型的结构、功能、作用机制及其在多囊卵巢综合征中的异常表达做简要综述。     

口服牛奶小茴香汁联合手法按揉治疗早期急性乳腺炎

目的 探讨口服牛奶小茴香汁联合手法按揉治疗早期急性乳腺炎的治疗效果。方法应用自制牛奶小茴香汁口服联合手法按揉治疗早期急性乳腺炎46例。结果 治愈44例，治愈时间1～9d，治愈率达95．6％。无1例发生不良反应。结论 口服牛奶小茴香汁联合手法按揉治疗早期急性乳腺炎的方法疗效好、见效快。     

The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.

BACKGROUND AND PURPOSE: The potential risk of prolongation of treatment time in cervical cancer has been reported for many low-dose rate (LDR) studies, with an estimated loss of local control ranging from 0.3 to 1.6% per day of treatment prolongation. Since the treatment schedule for fractionated high-dose rate intracavitary brachytherapy (HDRICB) is not directly comparable with that for low-dose rate studies, this report aims to evaluate the adverse effect of treatment prolongation specifically for cervical cancer treated with HDRICB. MATERIAL AND METHODS: From September 1992 to December 1997, 257 patients diagnosed with uterine cervical cancer (35 Ib, 26 IIa, 122 IIb, 10 IIIa, 57 IIIb, 7 IVa), who underwent external radiotherapy combined with between two and four courses of HDRICB and a minimum of 3 years of follow-up (median 57 months), were analyzed. Treatment consisted of irradiation of the whole pelvis with 44-45 Gy consisting of 22-25 fractions by 5 weeks, with the dose boosted to 54-58 Gy (with central shielding) for patients diagnosed as FIGO stage IIb-IVa bilateral parametrial disease. HDRICB was performed using an Ir-192 remote afterloading technique at 1-week intervals. The standard prescribed dose for each course of HDRICB was 7.2 Gy to point A for three insertions (before July 1995), or 6.0 Gy to point A for four insertions (after July 1995). Total prescribed point A doses (external beam radiotherapy+HDRICB) ranged from 58 to 71.6 Gy (median, 65.6 Gy) for stage IB-IIA, while analogous dosage for larger lesions (stage IIb-IVa) ranged from 59 to 75.6 Gy (median, 65.6 Gy). Kaplan-Meier and multivariate analyses were used to test the effect of treatment time on pelvic control rate (PCR) and cause-specific survival (CSS) at 5 years. RESULTS: Median treatment time was 63 days. For all stages of disease, the 5-year CSS and PCR were significantly different comparing treatment times of less than and greater than or equal to 63 days [83% and 65% (P=0.004], 93% and 83% (P=0.02), respectively]. These associations were also significant for stage Ib/IIa [97% and 79% (P=0.01), and 100% and 87% (P=0.02), respectively), but not for stage IIb [75% and 72% (P=0.79), and 93% and 87% (P=0.83), respectively] or stage III [66% and 49% (P=0.2), and 83% and 72% (P=0.21), respectively]. Multivariate analysis identified three prognostic factors for CSS, stage (P<0.001), tumor response to external RT (P=0.001), and overall treatment time (OTT; P=0.006). Prognostic factors for pelvic failure were stage (P<0.001), tumor response to external RT (P=0.001), and OTT (P=0.03). Prolongation of treatment time resulted in a daily decrease in pelvic control rate of 0.67% overall, and 0.43% for stage Ib-IIa, 0.57% for stage IIb, and 0.73% for stage III patients. CONCLUSION: Analysis of the data from the current study demonstrates that the adverse effect of treatment prolongation was observed later in the treatment course for the high-dose rate (HDR) series compared to the LDR analog, however, treatment-time prolongation still negatively influenced the cause-specific survival and pelvic control rate for both dosage groups.     

Ⅰ期全身麻醉下快速牵引复位及前路减压融合治疗下颈椎脱位

目的探讨Ⅰ期全身麻醉下快速牵引复位在治疗下颈椎脱位中的作用. 方法本组135例, 男101例,女34例;平均年龄44.4岁.单纯脱位81例,脱位伴骨折54例.单侧小关节脱位56例,双侧79例.53例采用全身麻醉下冠状颅骨牵引复位,38例采用床旁牵引复位,44例未行术前牵引复位. 结果 52例全身醉麻下复位成功,1例失败,成功率98.1%;18例床旁牵引复位成功,20例失败,成功率47.4%.复位成功的70例均行颈前路间盘或椎体次全切除、植骨、前路钛板固定;未复位65例中,33例采取前后联合入路手术,17例采取后路关节突切除、复位、关节突钢板固定术,15例行颈前路间盘或椎体次全切除、植骨、前路钛板固定.所有患者均无术后神经损伤加重. 结论全身麻醉下颅骨牵引复位可以显著提高复位成功率,且脊髓损伤概率小,对手术方式有着重要影响.     

火药爆炸复合烧伤大鼠血浆CK-MB与心肌MDA变化

目的 探讨烟花火药爆炸复合烧伤大鼠血浆肌酸激酶心肌同工酶(CK—MB)与心肌丙二醛(MDA)含量的变化。方法 Wistar大鼠128只，随机分为正常对照组(n=8)、烧伤组(n=40)、爆炸伤组(n=40)和复合伤组(n=40)，分别致伤形成大鼠20％体表面积Ⅲ度烧伤、火药爆炸伤和两者复合伤。动态观察大鼠伤后1、3、6、12、24h血浆CK—MB，心肌MDA含量并进行相关分析。结果 复合伤组较单因素致伤组大鼠血浆CK—MB升高明显，心肌组织MDA含量呈类似变化，CK—MB与MDA有相关性。结论 烟花火药爆炸复合烧伤对大鼠心肌的损害较单纯烧伤或爆炸伤更为严重，提示烧伤和爆炸伤有协同致伤作用，氧自由基代谢紊乱参与烟花火药爆炸复合烧伤后心肌的损伤。     

难治性癫痫皮层电极监测的观察和护理：附14例报告

癫痫是由于脑灰质内某些高兴奋性细胞群过度重复放电所引起的一种l临床征象，其中大约20％不能通过药物控制发作，称为难治性癫痫，需手术治疗。致痫灶的精确定位是保证癫痫手术效果的关键。随着医疗技术的不断发展，一种具有脑电记录灵敏度高、定位精确等优点的长程视频脑电监测技术已经诞生并应用于l临床。该监测技术避免了头皮、颅骨等不良介质的影响和肌电、身体活动等因素的干扰，可以直接记录大脑皮层和深部脑组织的脑电活动，已在临床中广泛采用。     

女性控尿解剖学机制的MRI研究

目的探讨女性控尿的解剖学机制在MRI（磁共振成像）的表现和观察方法。方法对20例正常控尿的成年女性进行MRI扫描，采用八通道体部线圈、快束自旋回波（FSE）扫描序列进行扫描，采集静息时盆腔横断面、矢状面和冠状面影像。结果MRI显示，女性的尿道分三层结构，与病理学对照，由内向外依次为黏膜及黏膜下组织、肌肉、外膜组织，但无法区分平滑肌与括约肌；与控尿有关的盆底肌肉也能够清楚显示。结论MRI能够清楚观察到女性控尿的有关解剖结构，是观察女性控尿解剖结构的较理想影像方法。     

降调节对卵子质量的影响

近10余年来，在体外受精一胚胎移植（IVF-ET）周期中应用促性腺激素释放激素激动剂（GnRH-a）进行控制性卵巢刺激（COS）已成为普遍采用的方法，其主要原因是GnRH-a可以促进卵巢内多个卵泡同步发育和成熟，抑制内源性黄体生成素（LH）峰，阻遏卵泡过早黄素化及卵子早熟。由于GnRH-a在IVF-ET进行降调节COS中的应用不同，可将COS方案分为长方案和短方案。[第一段]